Combined Antiviral Therapy Using Designed Molecular Scaffolds Targeting Two Distinct Viral Functions, HIV-1 Genome Integration and Capsid Assembly
Designed molecular scaffolds have been proposed as alternative therapeutic agents against HIV-1. The ankyrin repeat protein (Ank < sup > GAG < /sup > 1D4) and the zinc finger protein (2LTRZFP) have recently been characterized as intracellular antivirals, but these molecules, used indivi...
Saved in:
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84940053734&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/44227 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
id |
th-cmuir.6653943832-44227 |
---|---|
record_format |
dspace |
spelling |
th-cmuir.6653943832-442272018-04-25T07:47:13Z Combined Antiviral Therapy Using Designed Molecular Scaffolds Targeting Two Distinct Viral Functions, HIV-1 Genome Integration and Capsid Assembly Wannisa Khamaikawin Somphot Saoin Sawitree Nangola Koollawat Chupradit Supachai Sakkhachornphop Sudarat Hadpech Nattawat Onlamoon Aftab A. Ansari Siddappa N. Byrareddy Pierre Boulanger Saw See Hong Bruce E. Torbett Chatchai Tayapiwatana Agricultural and Biological Sciences Designed molecular scaffolds have been proposed as alternative therapeutic agents against HIV-1. The ankyrin repeat protein (Ank < sup > GAG < /sup > 1D4) and the zinc finger protein (2LTRZFP) have recently been characterized as intracellular antivirals, but these molecules, used individually, do not completely block HIV-1 replication and propagation. The capsid-binder Ank < sup > GAG < /sup > 1D4, which inhibits HIV-1 assembly, does not prevent the genome integration of newly incoming viruses. 2LTRZFP, designed to target the 2-LTR-circle junction of HIV-1 cDNA and block HIV-1 integration, would have no antiviral effect on HIV-1-infected cells. However, simultaneous expression of these two molecules should combine the advantage of preventive and curative treatments. To test this hypothesis, the genes encoding the N-myristoylated Myr(+)Ank < sup > GAG < /sup > 1D4 protein and the 2LTRZFP were introduced into human T-cells, using a third-generation lentiviral vector. SupT1 cells stably expressing 2LTRZFP alone or with Myr(+)Ank < sup > GAG < /sup > 1D4 showed a complete resistance to HIV-1 in viral challenge. Administration of the Myr(+)Ank < sup > GAG < /sup > 1D4 vector to HIV-1-preinfected SupT1 cells resulted in a significant antiviral effect. Resistance to viral infection was also observed in primary human CD4+ T-cells stably expressing Myr(+)Ank < sup > GAG < /sup > 1D4, and challenged with HIV-1, SIVmac, or SHIV. Our data suggest that our two anti-HIV-1 molecular scaffold prototypes are promising antiviral agents for anti-HIV-1 gene therapy. 2018-01-24T04:39:38Z 2018-01-24T04:39:38Z 2015-08-25 Journal 21622531 2-s2.0-84940053734 10.1038/mtna.2015.22 https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84940053734&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/44227 |
institution |
Chiang Mai University |
building |
Chiang Mai University Library |
country |
Thailand |
collection |
CMU Intellectual Repository |
topic |
Agricultural and Biological Sciences |
spellingShingle |
Agricultural and Biological Sciences Wannisa Khamaikawin Somphot Saoin Sawitree Nangola Koollawat Chupradit Supachai Sakkhachornphop Sudarat Hadpech Nattawat Onlamoon Aftab A. Ansari Siddappa N. Byrareddy Pierre Boulanger Saw See Hong Bruce E. Torbett Chatchai Tayapiwatana Combined Antiviral Therapy Using Designed Molecular Scaffolds Targeting Two Distinct Viral Functions, HIV-1 Genome Integration and Capsid Assembly |
description |
Designed molecular scaffolds have been proposed as alternative therapeutic agents against HIV-1. The ankyrin repeat protein (Ank < sup > GAG < /sup > 1D4) and the zinc finger protein (2LTRZFP) have recently been characterized as intracellular antivirals, but these molecules, used individually, do not completely block HIV-1 replication and propagation. The capsid-binder Ank < sup > GAG < /sup > 1D4, which inhibits HIV-1 assembly, does not prevent the genome integration of newly incoming viruses. 2LTRZFP, designed to target the 2-LTR-circle junction of HIV-1 cDNA and block HIV-1 integration, would have no antiviral effect on HIV-1-infected cells. However, simultaneous expression of these two molecules should combine the advantage of preventive and curative treatments. To test this hypothesis, the genes encoding the N-myristoylated Myr(+)Ank < sup > GAG < /sup > 1D4 protein and the 2LTRZFP were introduced into human T-cells, using a third-generation lentiviral vector. SupT1 cells stably expressing 2LTRZFP alone or with Myr(+)Ank < sup > GAG < /sup > 1D4 showed a complete resistance to HIV-1 in viral challenge. Administration of the Myr(+)Ank < sup > GAG < /sup > 1D4 vector to HIV-1-preinfected SupT1 cells resulted in a significant antiviral effect. Resistance to viral infection was also observed in primary human CD4+ T-cells stably expressing Myr(+)Ank < sup > GAG < /sup > 1D4, and challenged with HIV-1, SIVmac, or SHIV. Our data suggest that our two anti-HIV-1 molecular scaffold prototypes are promising antiviral agents for anti-HIV-1 gene therapy. |
format |
Journal |
author |
Wannisa Khamaikawin Somphot Saoin Sawitree Nangola Koollawat Chupradit Supachai Sakkhachornphop Sudarat Hadpech Nattawat Onlamoon Aftab A. Ansari Siddappa N. Byrareddy Pierre Boulanger Saw See Hong Bruce E. Torbett Chatchai Tayapiwatana |
author_facet |
Wannisa Khamaikawin Somphot Saoin Sawitree Nangola Koollawat Chupradit Supachai Sakkhachornphop Sudarat Hadpech Nattawat Onlamoon Aftab A. Ansari Siddappa N. Byrareddy Pierre Boulanger Saw See Hong Bruce E. Torbett Chatchai Tayapiwatana |
author_sort |
Wannisa Khamaikawin |
title |
Combined Antiviral Therapy Using Designed Molecular Scaffolds Targeting Two Distinct Viral Functions, HIV-1 Genome Integration and Capsid Assembly |
title_short |
Combined Antiviral Therapy Using Designed Molecular Scaffolds Targeting Two Distinct Viral Functions, HIV-1 Genome Integration and Capsid Assembly |
title_full |
Combined Antiviral Therapy Using Designed Molecular Scaffolds Targeting Two Distinct Viral Functions, HIV-1 Genome Integration and Capsid Assembly |
title_fullStr |
Combined Antiviral Therapy Using Designed Molecular Scaffolds Targeting Two Distinct Viral Functions, HIV-1 Genome Integration and Capsid Assembly |
title_full_unstemmed |
Combined Antiviral Therapy Using Designed Molecular Scaffolds Targeting Two Distinct Viral Functions, HIV-1 Genome Integration and Capsid Assembly |
title_sort |
combined antiviral therapy using designed molecular scaffolds targeting two distinct viral functions, hiv-1 genome integration and capsid assembly |
publishDate |
2018 |
url |
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84940053734&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/44227 |
_version_ |
1681422520413061120 |